Effect of symbiotic supplement on breast cancer recurrence

Not Applicable

Recruiting

• Conditions: Breast cancer.; Malignant neoplasm of breast

• Registration Number: IRCT20091114002709N49
• Lead Sponsor: Iran University of Medical Sciences

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Last Update Posted: 18 June 2018

Recruitment & Eligibility

• Status: Recruiting
• Sex: Female
• Target Recruitment: 76

Inclusion Criteria

Female breast cancer survivors (or Cessation of menstruation for at least 6 months prior to chemotherapy)
Age range (50-75)
BMI = 25 - 40 Kg/m2
At least one month has passed since the last radiotherapy
Complete treatment of stage 1 - 4 breast cancer survivors
Type of breast cancer : ER/PR+ and HER2-
Willingness to cooperate and sign a written informed consent

Exclusion Criteria

History of Diabetes, acute heart failure, cirrhosis hepatic, acute and chronic renal failure
History of autoimmune and infectious disease
weight loss diet during the 6 months prior to study
Smoking
Alcohol consumption
Nutrition supplement consumption

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Adiponectin. Timepoint: Before intervention and 8 weeks after the start of intervention. Method of measurement: Elisa method.

Secondary Outcome Measures

Name	Time	Method
Tumor Necrosis Factor alpha (TNF-a). Timepoint: Before intervention and 8 weeks after the start of intervention. Method of measurement: Elisa method.;High-sensitivity C-reactive protein (hs-CRP). Timepoint: Before intervention and 8 weeks after the start of intervention. Method of measurement: Elisa method.;Apolipoprotein-A1 (Apo-A1). Timepoint: Before intervention and 8 weeks after the start of intervention. Method of measurement: Elisa method.;Apolipoprotein-B100 (Apo-B100). Timepoint: Before intervention and 8 weeks after the start of intervention. Method of measurement: Elisa method.